Why Clinical Trial Registration Is Not Enough Without Results Reporting
A registered protocol helps reveal what was planned; timely summary results reveal what actually happened.
Wirenova Staff
A clinical-trial registration number is a sign of transparency, but it is not proof that the evidence became publicly available. Registration records what researchers planned to study. Results reporting records what they found. The scientific record needs both.
The World Health Organization calls for trials to be registered in a publicly accessible registry before the first participant is enrolled. Prospective registration creates a time-stamped record of the intervention, outcomes, population, and design. That record makes it harder to hide an unfavourable trial or quietly replace a disappointing primary outcome with a more attractive one.
Registration answers “what was planned?”
A useful registration entry allows readers to compare the protocol with the eventual analysis. If the primary outcome, sample size, or time point changes, the change may be legitimate—but it should be visible and explained.
Incomplete or late registration weakens that protection. A record created after investigators have seen some data cannot provide the same independent evidence of what was decided in advance.
Results reporting answers “what happened?”
Summary results normally include participant flow, baseline characteristics, outcome data, and adverse events. WHO’s updated guidance sets minimum reporting elements intended to make registry results useful and comparable.
A trial can be perfectly registered and still disappear after completion. That creates publication bias: positive or dramatic findings are more likely to reach the public record, while negative, inconclusive, or commercially inconvenient results remain unseen. Systematic reviews and clinical guidelines can then overestimate benefits or underestimate harms.
A registry is not a journal, and a journal is not a registry
Journal articles offer interpretation, methodological detail, and peer review. Registries provide a structured public record and can publish summary results even when a journal article is delayed or never accepted. One does not replace the other.
The World Health Organization has promoted timely registry reporting as a global norm, while the US National Institutes of Health requires registration and results submission for covered NIH-funded trials under policy and applicable US law. Exact legal deadlines depend on the trial and jurisdiction, so sponsors must identify the rules that apply to their study.
Transparency is an ethical obligation
Participants accept inconvenience and risk partly because their contribution may improve knowledge. Failing to report a completed trial wastes that contribution. It can also cause future volunteers and researchers to repeat an unsuccessful or hazardous approach because prior evidence was not visible.
Transparency also benefits sponsors. A complete record demonstrates that negative findings are handled through a consistent policy rather than released selectively when convenient.
What research organizations should do
Responsibility should be assigned before recruitment begins. The protocol should name who will register the study, maintain the record, submit results, and respond to registry queries. Completion dates should trigger reminders well before reporting deadlines.
Quality control is necessary. Registry results should agree with the analysed dataset and clearly describe the outcome measure, time point, population, and statistical result. Missing values and deviations should be explained. A link to a publication is useful, but it should not be treated as a substitute when structured results are required.
Institutions can audit compliance by matching ethics approvals and study-management records against registries. Funders and journals can reinforce the system by checking prospective registration and reporting history.
What readers should check
When evaluating a published trial, readers can compare the paper with the original registry entry. Was registration prospective? Are the primary outcomes the same? Were all prespecified outcomes reported? Is a summary-results record available? Are important changes dated and explained?
The bottom line
Registration and reporting solve different parts of the same problem. Registration makes the plan visible before results can influence it. Results reporting makes the outcome visible whether it is positive, negative, or inconclusive. Scientific transparency is incomplete when either half is missing.
Topics
Sources used
- World Health OrganizationReporting on findings from clinical trials
- US National Institutes of HealthNIH clinical trial reporting requirements
Sources support the factual claims in this explainer. Wirenova’s wording and structure are original.
